EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Other Sources: 11

Phosphatidylserine

Also called: PS, soy phosphatidylserine

Phosphatidylserine is a phospholipid, a building block of cell membranes. Early research used phosphatidylserine from cow brain; supplements sold today include soybean-derived phosphatidylserine, sometimes combined with phosphatidic acid.

Category
Other
Forms
Soy-derived phosphatidylserine; phosphatidylserine–phosphatidic acid complex (PAS)
Strongest evidence
C Limited
Reviewed
2026-10-28

Class 2 Moderately studied in people. No review stating a count of single-ingredient trials was found. This entry cites 4 RCTs of oral phosphatidylserine alone versus placebo (1986–2026), plus one placebo-controlled crossover trial whose abstract does not state randomization. Trials of phosphatidylserine with phosphatidic acid (PAS) are not counted. [5]

Fact-checked 2026-10-28 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

5 topics studied2 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Phosphatidylserine does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Phosphatidylserine, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Cortisol response to a psychological stress testCA randomized trial (4 groups of 20, 3 weeks) found 400 mg/day of a soy PS–phosphatidic acid complex blunted ACTH and cortisol responses to a social stress test; 600 and 800 mg did not. [1]
Stress hormones in chronically stressed menCIn a 42-day randomized trial in 75 men, 400 mg PS plus 400 mg phosphatidic acid daily normalized ACTH and cortisol stress responses only in highly stressed men, with no effect on psychological stress response. [2]
Cortisol response to exerciseCA crossover trial in 10 healthy men (600 mg/day for 10 days) found lower peak cortisol (by 39%) and cortisol area under the curve after moderate cycling than placebo. [3]
Premenstrual syndromeCA randomized trial in 40 women (400 mg PS plus 400 mg phosphatidic acid daily for 3 cycles) found greater improvement in total PMS symptom score than placebo; most individual symptom scales did not differ. [4]
Memory in older adults with age-associated memory impairmentXA 12-week randomized trial in 120 adults over 57 (300 or 600 mg/day soy-derived PS) found no effect on memory or other cognitive functions. [5]
Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • 300 or 600 mg/day of soy-derived PS for 12 weeks (older adults). [5]
  • 400 mg PS plus 400 mg phosphatidic acid per day for 42 days. [2]
  • 600 mg/day for 10 days (exercise study). [3]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • In 120 older adults, 300 or 600 mg/day of soy-derived PS for 12 weeks caused no differences from placebo in blood tests, blood pressure, heart rate or adverse events. [6]
  • 400 mg PS plus 400 mg phosphatidic acid daily over 3 menstrual cycles was considered safe in the PMS trial. [4]
Regulation

Regulatory status

  • US: FDA lists qualified health claim letters (enforcement discretion, not approval) titled "Phosphatidylserine and Cognitive Dysfunction and Dementia" (February 24 and May 13, 2003), updated November 24, 2004. [7]
  • US: FDA states that, by law, it does not approve dietary supplements or their labeling before they are marketed; firms are responsible for the safety and labeling of their products. [8]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Phosphatidylserine (PS) Phospholipid [P5]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming phosphatidylserine was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P1]
  • FDA's qualified health claims page lists letters of enforcement discretion titled "Phosphatidylserine and Cognitive Dysfunction and Dementia" (February 24, 2003 and May 13, 2003) and a letter updating the claim (November 24, 2004). Enforcement discretion is not an approval. [P6]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC carcinogenicity evaluation of phosphatidylserine was found (IARC Monographs list of classifications checked 2026-10-29). [P2]
  • No NTP carcinogenicity technical report on phosphatidylserine was found (NTP technical reports list checked 2026-10-29). [P3]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each dietary-ingredient component — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants a petition-based exemption under 111.75(a)(1)(ii). [P4]

Supply and conservation

  • Phosphatidylserine can be derived from several sources: earlier studies used brain-cortex-derived PS, while soybean-derived PS is widely sold as a nutritional supplement. [P5]

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. IARC Monographs. List of Classifications (list last updated 2026-07-23 per page data; checked 2026-10-29), 2026-07-23. monographs.iarc.who.int
  3. National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
  4. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  5. Jorissen BL, et al. Safety of soy-derived phosphatidylserine in elderly people. Nutr Neurosci 2002;5(5):337-43 (PMID 12385596), 2002-10. pubmed.ncbi.nlm.nih.gov
  6. U.S. FDA. Qualified Health Claims: Letters of Enforcement Discretion (content current as of 03/28/2024), 2024-03-28. fda.gov
Sources

Sources

  1. Hellhammer J, et al. Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress. Stress 2004;7(2):119-26 (PMID 15512856), 2004-06. pubmed.ncbi.nlm.nih.gov
  2. Hellhammer J, et al. A soy-based phosphatidylserine/phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects. Lipids Health Dis 2014;13:121 (PMID 25081826), 2014-07-31. pubmed.ncbi.nlm.nih.gov
  3. Starks MA, et al. The effects of phosphatidylserine on endocrine response to moderate intensity exercise. J Int Soc Sports Nutr 2008;5:11 (PMID 18662395), 2008-07-28. pubmed.ncbi.nlm.nih.gov
  4. Schmidt K, et al. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): results of a randomized, placebo-controlled, double-blind clinical trial. Clin Nutr ESPEN 2018 (PMID 29576358), 2018-04. pubmed.ncbi.nlm.nih.gov
  5. Jorissen BL, et al. The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment. Nutr Neurosci 2001;4(2):121-34 (PMID 11842880), 2001. pubmed.ncbi.nlm.nih.gov
  6. Jorissen BL, et al. Safety of soy-derived phosphatidylserine in elderly people. Nutr Neurosci 2002;5(5):337-43 (PMID 12385596), 2002-10. pubmed.ncbi.nlm.nih.gov
  7. U.S. FDA. Qualified Health Claims: Letters of Enforcement Discretion (content current as of 03/28/2024), 2024-03-28. fda.gov
  8. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
  9. Delwaide PJ, et al. Double-blind randomized controlled study of phosphatidylserine in senile demented patients. Acta Neurol Scand 1986;73(2):136-40 (PMID 3518329), 1986-02. pubmed.ncbi.nlm.nih.gov
  10. Hirayama S, et al. The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial. J Hum Nutr Diet 2014;27 Suppl 2:284-91 (PMID 23495677), 2014-04. pubmed.ncbi.nlm.nih.gov
  11. McMillan NJ, et al. Beneficial vascular effects of oral phosphatidylserine supplementation in type 2 diabetes. J Appl Physiol (1985) 2026;141(1):130-148 (PMID 42312814), 2026-07-01. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Betaine (trimethylglycine) · Bromelain · Caffeine · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.